It had managed to raise funding of $350 million back in April, led by Prosus Ventures and TPG Growth. Existing investors including Temasek, CDPQ, LGT Lightrock, Eight Roads, and Think Investments also participated in the series E round. With the round of investments the company officially became a unicorn.
API Holdings also has a majority stake in Thyrocare. The company had announced in June that it had acquired a 66.1 percent stake in Thyrocare from Dr A Velumani and affiliates at a price of Rs 1,300 per share aggregating to Rs 4,546 crore.